Editorial · 8 May 2017
Conference abstract
New roles for old players?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The aim of our study was to evaluate the effect on cancer cell viability and proliferation of some well-known commercially available drugs used in clinical practice for the treatment of other diseases: disulfiram (applied in the treatment of alcoholism), statins (lipid-lowering medication) and non-steroidal anti-inflammatory agents (meloxicam as well as its Zn(II), Co(II), Co(II) and Ni(II) complexes). The cytotoxic activity of the compounds was investigated in retrovirus-transformed LSCC-SF-Mc29 chicken hepatoma and LSR-SF-SR rat sarcoma cells that express oncogenes v-myc and v-src, respectively (in the case of disulfiram and statins) as well as in human cell lines established from breast MCF-7), colorectal (HT29) and liver (HepG2) cancer, non-small cell lung cancer (A549), uterine cervical carcinoma (HeLa) and glioblastoma multiforme (8MGBA). Lep-3 non-tumor human embryonic fibroblastoid cells were also used for comparative purposes. The experiments were performed by MTT test, neutral red uptake assay, crystal violet staining, hematoxylin and eosin staining, double staining with acridine orange and propidium iodide, Comet assay, 3D-colony forming method. The results obtained reveal that applied at concentrations of 1-50 ?g/ml (disulfiram and statins) and 10-500 ?g/ml (meloxicam and its metal complexes) the examined compounds decrease in a time- and concentration-dependent manner viability / 2D- and 3D-growth of the treated cells. Metal complexes of meloxicam are more effective cytotoxic agents as compared to meloxicam alone. Non-tumor Lep-3 cells are also sensitive to the cytotoxic activity of the compounds tested. Acknowledgement: Supported by National Science Fund, Bulgarian Ministry of Education and Science (Grant ??? ?????? ?? 02 30/ 12.12.2014) and a bilateral project between Bulgarian Academy of Sciences and Romanian Academy.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 2013
New Therapeutic Opportunities from Old Drugs: The Role of Nanotechnology?
Conference abstract · 24 Jun 2014
Thyroid hormones growth factor effect in ovarian cancer: Old players, new game
Review article · 2015
MicroRNAs: New Players in Anesthetic-Induced Developmental Neurotoxicity
Review article · 2021
The Role of Administrative Creativity in the Functioning of the Administration of Sports Clubs for Football in Iraq from the Point of View of Players of Excellent Clubs
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Radostina Ivaylova Alexandrova”
- BylineArticles whose byline prints “Desislav Dinev”
- BylineArticles whose byline prints “Tanya Zhivkova”
- BylineArticles whose byline prints “Milena Georgieva”
- BylineArticles whose byline prints “Georgi Miloshev”
- BylineArticles whose byline prints “RossenSpasov”
- BylineArticles whose byline prints “Albena Alexandrova”
- BylineArticles whose byline prints “GabrielaMarinescu”

